Literature DB >> 21396411

Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.

Wouter Hofkens1, Lilyanne C Grevers, Birgitte Walgreen, Teun J de Vries, Pieter J M Leenen, Vincent Everts, Gert Storm, Wim B van den Berg, Peter L van Lent.   

Abstract

UNLABELLED: The objective of this study was to determine the effect of systemic delivery of prednisolone phosphate (PLP) encapsulated within long circulating 'stealth' liposomes on bone erosion and osteoclast activity during experimental antigen-induced arthritis (AIA). Liposomal PLP strongly suppressed knee joint swelling, synovial infiltrate and bone erosion in antigen-induced arthritis. The number of active osteoclasts was not only suppressed in bone lesions near inflamed synovium, but also within the trabecular bone of the tibia, suggesting a systemic suppression of osteoclast activation. Furthermore, liposomal PLP directly blocked osteoclast differentiation and bone resorption in vitro while it also suppressed expression of osteoclast differentiation factors M-CSF and RANKL in the synovium. Targeting studies showed that liposomes are most efficiently phagocytosed by macrophages and early precursors of osteoclasts in the bone marrow rather than by mature osteoclasts, indicating a possible inhibition of osteoclast differentiation from an early stage.
CONCLUSION: Liposomal glucocorticoid delivery rather than free PLP offers a more efficacious way to inhibit both inflammation and bone erosion in rheumatoid arthritis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396411     DOI: 10.1016/j.jconrel.2011.03.001

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Bodhraj Acharya; Kamal D Moudgil
Journal:  Nanomedicine (Lond)       Date:  2019-04-02       Impact factor: 5.307

Review 2.  Nanomedicine delivers promising treatments for rheumatoid arthritis.

Authors:  Leena Kumari Prasad; Hannah O'Mary; Zhengrong Cui
Journal:  Nanomedicine (Lond)       Date:  2015-06-18       Impact factor: 5.307

3.  Peptide-directed liposomal delivery improves the therapeutic index of an immunomodulatory cytokine in controlling autoimmune arthritis.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  J Control Release       Date:  2018-08-04       Impact factor: 9.776

Review 4.  Clinical significance of metallothioneins in cell therapy and nanomedicine.

Authors:  Sushil Sharma; Afsha Rais; Ranbir Sandhu; Wynand Nel; Manuchair Ebadi
Journal:  Int J Nanomedicine       Date:  2013-04-16

Review 5.  Drug Trafficking into Macrophages via the Endocytotic Receptor CD163.

Authors:  Jonas Heilskov Graversen; Søren Kragh Moestrup
Journal:  Membranes (Basel)       Date:  2015-06-23

Review 6.  Application of liposomes in treatment of rheumatoid arthritis: quo vadis.

Authors:  Bhupinder Kapoor; Sachin Kumar Singh; Monica Gulati; Reena Gupta; Yogyata Vaidya
Journal:  ScientificWorldJournal       Date:  2014-02-04

7.  Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.

Authors:  Jan Kroon; Jeroen T Buijs; Geertje van der Horst; Henry Cheung; Maaike van der Mark; Louis van Bloois; Larissa Y Rizzo; Twan Lammers; Rob C Pelger; Gert Storm; Gabri van der Pluijm; Josbert M Metselaar
Journal:  Prostate       Date:  2015-02-08       Impact factor: 4.104

8.  A soft coral-derived compound, 11-epi-sinulariolide acetate suppresses inflammatory response and bone destruction in adjuvant-induced arthritis.

Authors:  Yen-You Lin; Yen-Hsuan Jean; Hsin-Pai Lee; Wu-Fu Chen; Yu-Min Sun; Jui-Hsin Su; Yi Lu; Shi-Ying Huang; Han-Chun Hung; Ping-Jyun Sung; Jyh-Horng Sheu; Zhi-Hong Wen
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

9.  Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation.

Authors:  Wouter Hofkens; Rik Schelbergen; Gert Storm; Wim B van den Berg; Peter L van Lent
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Intravenous delivery of HIV-based lentiviral vectors preferentially transduces F4/80+ and Ly-6C+ cells in spleen, important target cells in autoimmune arthritis.

Authors:  Ben T van den Brand; Eline A Vermeij; Claire E J Waterborg; Onno J Arntz; Michael Kracht; Miranda B Bennink; Wim B van den Berg; Fons A J van de Loo
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.